title: Plasma membrane Na(+)-H+ antiporter and H(+)-ATPase in the medullary thick ascending limb of rat kidney.
abstract: To characterize H+ transport mechanisms in a fresh suspension of rat medullary thick ascending limb (MTAL) tubules, we have monitored intracellular pH (pHi) with use of the fluorescent probe 2',7'-bis(carboxyethyl)-5,6-carboxyfluorescein. First, a Na(+)-H+ antiporter was identified in bicarbonate-free N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid (HEPES)-buffered media at 25 degrees C. pHi recovery of Na-depleted acidified cells was dependent on extracellular sodium concentration, which was inhibited by amiloride in a manner consistent with simple competitive interaction with one external transport site (amiloride Ki = 1.5-2.1 x 10(-5) M); Na-induced pHi recovery of acidified cells was electroneutral since it was not affected by 5 or 100 mM extracellular potassium in the presence or absence of valinomycin. Second, at 37 degrees C, pHi recovery after acute intracellular acidification caused by 40 mM acetate addition to cell suspension was inhibited 36% by 200-400 nM bafilomycin A1, a macrolide antibiotic that specifically inhibits vacuolar-type H(+)-ATPase at submicromolar concentrations. In addition, amiloride-insensitive pHi recovery was inhibited by bafilomycin A1, 10(-3) M N-ethylmaleimide, and 10(-4) M preactivated omeprazole but not by 10(-5) M vanadate, 10(-4) M SCH 28080, or removal of extracellular potassium. Also, metabolic inhibition by absence of substrate, 10(-4) M KCN, or 5 x 10(-4) M iodoacetic acid inhibited amiloride-insensitive pHi recovery. The inhibitory effects of absence of metabolic substrate and iodoacetic acid were removed by reexposure to glucose and L-leucine and by exogenous ATP, respectively.(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Laboratoire de Physiologie et Endocrinologie Cellulaire Rénale, Institut National de la Santé et de la Recherche Médicale U. 356, Université Pierre et Marie Curie, Paris, France.
authors.forename: M
authors.initials: M
authors.lastname: Froissart
authors.forename: P
authors.initials: P
authors.lastname: Borensztein
authors.forename: P
authors.initials: P
authors.lastname: Houillier
authors.forename: F
authors.initials: F
authors.lastname: Leviel
authors.forename: J
authors.initials: J
authors.lastname: Poggioli
authors.forename: E
authors.initials: E
authors.lastname: Marty
authors.forename: M
authors.initials: M
authors.lastname: Bichara
authors.forename: M
authors.initials: M
authors.lastname: Paillard
mesh_terms: D000584:Amiloride / Q000494:pharmacology; D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology; D002352:Carrier Proteins / Q000378:metabolism*; D002462:Cell Membrane / Q000378:metabolism; D006863:Hydrogen-Ion Concentration; D007679:Kidney Medulla; D008138:Loop of Henle / Q000378:metabolism*; D018942:Macrolides; D008297:Male; D006180:Proton-Translocating ATPases / Q000737:chemistry / Q000378:metabolism*; D051381:Rats; D011919:Rats, Inbred Strains; D012964:Sodium / Q000494:pharmacology; D017923:Sodium-Hydrogen Exchangers
chemical_list: D000900:Anti-Bacterial Agents; D002352:Carrier Proteins; D018942:Macrolides; D017923:Sodium-Hydrogen Exchangers; C057620:bafilomycin A; D000584:Amiloride; D012964:Sodium; D006180:Proton-Translocating ATPases